Evaluation of several micro RNA (miRNA) levels in children and adolescents with attention deficit hyperactivity disorder

Neuroscience Letters

Volumn 580, Issue , 2014, Pages 158-162

  Kandemir, Hasan ^a   Erdal, Mehmet Emin ^b   Selek, Salih ^c   Ay, Özlem Izci ^b   Karababa, Ibrahim Fatih ^a   Kandemir, Sultan Basmaci ^d   Ay, Mustafa Ertan ^b   Yilmaz, Şenay Görücü ^b   Bayazit, Hüseyin ^a   Taşdelen, Bahar ^b  

^a HARRAN UNIVERSITY   (Turkey)

^b MERSIN UNIVERSITY   (Turkey)

^c Medeniyet University   (Turkey)

^d Department of General Surgery   (Turkey)

Author keywords

ADHD; Child psychiatry; Micro RNA; MiRNA; Psychiatry

Indexed keywords

MICRORNA; MICRORNA 106B 5P; MICRORNA 107; MICRORNA 125B 5P; MICRORNA 155A 5P; MICRORNA 18A 5P; MICRORNA 22 3P; MICRORNA 24 3P; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADOLESCENT; ADOLESCENT DISEASE; AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; CENTRAL NERVOUS SYSTEM FUNCTION; CHILD; CHILDHOOD DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; EVALUATION STUDY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; PATHOGENESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SEX DIFFERENCE; SIGNAL TRANSDUCTION; METABOLISM;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOLOGICAL MARKERS; CHILD; FEMALE; HUMANS; MALE; MICRORNAS;

EID: 84906514233     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.07.060     Document Type: Article

References (44)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Text-Revision (DSM-IVTR) 2000, American Psychiatric Association, Washington, DC. fourth ed.
2. Angold A., Erkanli A., Egger H.L., Costello E.J. Stimulant treatment for children: a community perspective. J. Am. Acad. Child Adolesc. Psychiatry 2000, 39(8):975-984.
3. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol. Psychiatry 2005, 57(11):1215-1220.
4. Yüce M., Zoroglu S.S., Ceylan M.F., Kandemir H., Karabekiroglu K. Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: a study from Turkey. Neuropsychiatr. Dis. Treat. 2013, 9:1791-1799.
5. Barkley R.A. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J. Clin. Psychiatry 2002, 63(Suppl. 12):10-15.
6. Kieling C., Goncalves R.R., Tannock R., Castellanos F.X. Neurobiology of attention deficit hyperactivity disorder. Child Adolesc. Psychiatr. Clin. North Am. 2008, 17(2):285-307.
7. Andrés Martin, Lawrence Scahill, Charney Dennnis S., Leckman James F. Pediatric Psychopharmacology: Principles and Practice 2003, 447-465. Oxford University Press, Oxford.
8. Rhee S.H., Waldman I.D. Genetic and environmental influences on antisocial behavior: a meta-analysis of twin and adoption studies. Psychol. Bull. 2002, 128(3):490-529.
9. Levy F. The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust. N.Z. J. Psychiatry 1991, 25:277-283.
10. Faraone S.V., Biederman J., Weiffenbach B., Keith T., Chu M.P., Weaver A., Spencer T.J.,..., Wilens T.E., Frazier J., Cleves M., Sakai J. Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am. J. Psychiatry 1999, 156(5):768-770.
11. Zoroǧlu S.S., Erdal M.E., Alaşehirli B., Erdal N., Sivasli E., Tutkun H., Savaş H.A., Herken H. Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiology 2002, 45(4):176-181.
12. Chekulaeva M., Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr. Opin. Cell Biol. 2009, 21(3):452-460.
13. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human microRNA targets. PLoS Biol. 2004, 2(11):e363.
14. Corbin R., Olsson-Carter K., Slack F. The role of microRNAs in synaptic development and function. BMB Rep. 2009, 42(3):131-135.
15. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136(2):215-233.
16. Perkins D.O., Jeffries C.D., Jarskog L.F., Thomson J.M., Woods K., Newman M.A., Parker J.S., Jin J., Hammond S.M. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 2007, 8(2):R27.
17. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., Williamson D., Ryan N. Schedule for affective disorders and schizophrenia for school-age children present and lifetime version (K-SADS-PL): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psychiatry 1997, 36:980-988.
18. Uchida S., Nishida A., Hara K., Kamemoto T., Suetsugi M., Fujimoto M., Watanuki T., Wakabayashi Y., Otsuki K., McEwen B.S., Watanabe Y. Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur. J. Neurosci. 2008, 27(9):2250-2261.
19. Vreugdenhil E., Verissimo C.S., Mariman R., Kamphorst J.T., Barbosa J.S., Zweers T., Champagne D.L., Schouten T., Meijer O.C., de Kloet E.R., Fitzsimons C.P. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 2009, 150(5):2220-2228.
20. Fortier M.È., Sengupta S.M., Grizenko N., Choudhry Z., Thakur G., Joober R. Genetic evidence for the association of the hypothalamic-pituitary-adrenal (HPA) axis with ADHD and methylphenidate treatment response. NeuroMol. Med. 2013, 15(1):122-132.
21. Khalife N., Glover V., Taanila A., Ebeling H., Järvelin M.R., Rodriguez A. Prenatal glucocorticoid treatment and later mental health in children and adolescents. PLoS One 2013, 8(11):e81394.
22. Muiños-Gimeno M., Espinosa-Parrilla Y., Guidi M., Kagerbauer B., Sipilä T., Maron E., Pettai K., Kananen L., Navinés R., Martín-Santos R., Gratacòs M., Metspalu A., Hovatta I., Estivill X. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol. Psychiatry 2011, 69(6):526-533.
23. Fones C.S., Pollack M.H., Susswein L., Otto M. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. J. Affective Disord. 2000, 58(2):99-106.
24. Moreau M.P., Bruse S.E., David-Rus R., Buyske S., Brzustowicz L.M. Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 2011, 69(2):188-193.
25. Beveridge N.J., Cairns M.J. MicroRNA dysregulation in schizophrenia. Neurobiol. Dis. 2012, 46(2):263-271.
26. Smalheiser N.R., Lugli G., Zhang H., Rizavi H., Cook E.H., Dwivedi Y. Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects. PLoS One 2014, 9(1):e86469.
27. Abu-Elneel K., Liu T., Gazzaniga F.S., Nishimura Y., Wall D.P., Geschwind D.H., Lao K., Kosik K.S. Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 2008, 9(3):153-161.
28. Sarachana T., Zhou R., Chen G., Manji H.K., Hu V.W. Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med. 2010, 2(4):23.
29. Nelson P.T., Wang W.X. MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J. Alzheimers Dis. 2010, 21(1):75-79.
30. Wang W.X., Wilfred B.R., Madathil S.K., Tang G., Hu Y., Dimayuga J., Stromberg A.J., Huang Q., Saatman K.E., Nelson P.T. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am. J. Pathol. 2010, 177(1):334-345.
31. Santarelli D.M., Beveridge N.J., Tooney P.A., Cairns M.J. Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry 2011, 69(2):180-187.
32. Smalheiser N.R., Lugli G., Rizavi H.S., Torvik V.I., Turecki G., Dwivedi Y. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One 2012, 7(3):e33201.
33. Chen H., Wang N., Burmeister M., McInnis M.G. MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int. J. Neuropsychopharmacol. 2009, 12(7):975-981.
34. Eipper-Mains J.E., Kiraly D.D., Palakodeti D., Mains R.E., Eipper B.A., Graveley B.R. microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs. RNA 2011, 17(8):1529-1543.
35. Ghose J., Sinha M., Das E., Jana N.R., Bhattacharyya N.P. Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease. PLoS One 2011, 6(8):e23837.
36. Wang W.X., Huang Q., Hu Y., Stromberg A.J., Nelson P.T. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 2011, 121(2):193-205.
37. Cogswell J.P., Ward J., Taylor I.A., Waters M., Shi Y., Cannon B., Kelnar K., Kemppainen J., Brown D., Chen C., Prinjha R.K., Richardson J.C., Saunders A.M., Roses A.D., Richards C.A. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 2008, 14(1):27-41.
38. Huang Z.H., Huang D., Ni S.J.A., Peng Z.L., Sheng W.Q., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 2010, 127:118e26.
39. Maffioletti E., Tardito D., Gennarelli M., Bocchio-Chiavetto L. Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. Front. Cell. Neurosci. 2014, 11(8):75.
40. Selek S., Bulut M., Ocak A.R., Kalenderoǧlu A., Savaş H.A. Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications. J. Psychiatr. Res. 2012, 46(4):451-455.
41. Song L., Lin C., Wu Z., Gong H., Zeng Y., Wu J., Li M., Li J. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS One 2011, 6(9):e25454. 10.1371/journal.pone.0025454.
42. Morrow J.D., Frei B., Longmire A.W., Gaziano J.M., Lynch S.M., Shyr Y., Strauss W.E., Oates J.A., Roberts L.J. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N. Engl. J. Med. 1995, 332(18):1198-1203.
43. Dhar S., Hicks C., Levenson A.S. Resveratrol and prostate cancer: promising role for microRNAs. Mol. Nutr. Food Res. 2011, 55(8):1219-1229. 10.1002/mnfr.201100141.
44. Buroker N.E., Ning X.H., Zhou Z.N., Li K., Cen W.J., Wu X.F., Chen S.H. Circulating miRNAs from Dried Blood Spots are Associated with High Altitude Sickness. J. Med. Diagn. Methods 2013.